Safety of hepatitis E vaccination for pregnancy: a post-hoc analysis of a randomized, double-blind, controlled phase 3 clinical trial

Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Head-to-head immunogenicity comparison of an<i> Escherichia</i> coli-produced 9-valent human papillomavirus vaccine and Gardasil 9 in women aged 18-26 years in China: a randomised blinded clinical trial

The epidemiology of varicella and effectiveness of varicella vaccine in Ganyu, China: a long-term community surveillance study

Reconsideration of Maternal Serological Testing for Predicting Congenital CMV Infection

Anti-Epstein-Barr Virus BNLF2b for Mass Screening for Nasopharyngeal Cancer

Safety and immunogenicity of an<i> Escherichia</i> coli-produced 9-valent human papillomavirus L1 virus-like particle vaccine (types 6/11/16/18/31/33/45/52/58) in healthy adults: an open-label, dose-escalation phase 1 clinical trial

Safety and immunogenicity of a skin- and neuro-attenuated live vaccine for varicella: a randomized, double-blind, controlled, dose-escalation and age de-escalation phase 1 clinical trial

Immunogenicity and safety of an<i> Escherichia</i> coli-produced human papillomavirus (types 6/11/16/18/31/33/45/52/58) L1 virus-like-particle vaccine: a phase 2 double-blind, randomized, controlled trial